Twist Bioscience (TWST) | Stock Overview & Key Data
Twist Bioscience Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $214.07 on January 18, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Twist Bioscience
TWST
|
3.61B Mid-cap | 15.35% | 64.31% | 79.49% | 160.03% | 149.43% | 127.24% | 316.00% | -31.53% | 444.07% | 444.07% | 444.07% |
|
Thermo Fisher
TMO
|
174.55B Large-cap | 0.87% | 8.07% | 0.79% | -17.74% | -20.05% | 16.53% | -12.65% | -2.72% | 220.94% | 654.32% | 1,231.84% |
|
Danaher
DHR
|
126.39B Large-cap | -1.32% | 11.85% | -5.38% | -20.75% | -21.40% | -10.25% | -15.98% | -20.94% | 174.08% | 416.93% | 738.84% |
|
Revvity
RVTY
|
9.74B Mid-cap | 0.25% | 7.00% | 16.27% | 1.48% | 2.45% | 6.55% | -16.43% | -33.86% | 90.37% | 284.64% | 376.61% |
|
Icon plc
ICLR
|
8.98B Mid-cap | -2.97% | 26.93% | 51.34% | -19.88% | -21.70% | 0.36% | -37.56% | -31.10% | 128.30% | 504.05% | 1,004.91% |
|
Charles River
CRL
|
8.28B Mid-cap | 1.09% | 24.94% | 24.02% | -4.89% | -6.89% | 25.47% | -10.71% | -46.99% | 128.42% | 379.20% | 406.37% |
Ownership & Short Interest
Calculate Your Twist Bioscience Investment Returns
Long-Term Investment Performance Analysis
Twist Bioscience stock price in Oct 2018 was $14.00, A $1,000.00 lump sum investment in Twist Bioscience made 7 years ago would be worth approximately $5,770.71 today, representing a exceptional return of 477.07%. This translates to an annualized return (CAGR) of 25.83%.
7 Years 7 Months Investment Scenario (Oct 2018 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is TWST's 52-week high and low?
- In the last 52 weeks, Twist Bioscience reached a high of $82.99 (on June 15, 2026) and a low of $23.30 (on November 14, 2025).
- What is the market cap and P/E ratio for TWST?
- Curious about Twist Bioscience's size and valuation? Its market capitalization stands at 3.61B. When it comes to valuation, the P/E ratio (trailing twelve months) is -45.26, and the forward P/E (looking ahead) is -33.53.
- Does TWST pay dividends? If so, what's the yield?
- As for dividends, Twist Bioscience isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Twist Bioscience's main competitors or similar companies to consider before investing?
When looking at Twist Bioscience, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.55B Healthcare Diagnostics & Research 16.53% -12.65% Danaher
DHR126.39B Healthcare Diagnostics & Research -10.25% -15.98% Revvity
RVTY9.74B Healthcare Diagnostics & Research 6.55% -16.43% Icon plc
ICLR8.98B Healthcare Diagnostics & Research 0.36% -37.56% Charles River
CRL8.28B Healthcare Diagnostics & Research 25.47% -10.71% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Twist Bioscience Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Twist Bioscience's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -16.79%, the Debt to Equity ratio from the most recent quarter is 24.79, and its Gross Profit Margin stands at 52.05%.
- What is the recent revenue and earnings growth for TWST?
- Looking at Twist Bioscience's growth, its revenue over the trailing twelve months (TTM) was $392M. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.90%, and quarterly earnings saw a YoY growth of 16.89%.
- How much of TWST stock is held by insiders and institutions?
- Wondering who owns Twist Bioscience stock? Company insiders (like executives and directors) hold about 1.50% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 122.49%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.